Advertisement

Topics

Clinical Trials About "Octapharma" RSS

17:24 EST 11th December 2018 | BioPortfolio

We list hundreds of Clinical Trials about "Octapharma" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Octapharma" on BioPortfolio

We have published hundreds of Octapharma news stories on BioPortfolio along with dozens of Octapharma Clinical Trials and PubMed Articles about Octapharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Octapharma Companies in our database. You can also find out about relevant Octapharma Drugs and Medications on this site too.

Showing "Octapharma" Clinical Trials, all 2

Relevant

Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment

Patients with primary or secondary immunodeficiency disease who have developed adverse reactions to products available on the market such as Cuvitru® (Shire), Hizentra® (CSL Behring) or 10% Gammunex® (Grifols), may benefit from utilizing 16.5% Cutaquig® (Octapharma).


Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

International, post-authorisation non-interventional study to evaluate real-life effectiveness, safety and utilisation patterns of Octapharma's FVIII concentrates Nuwiq, Octanate, and Wilate in previously untreated and minimally treated severe haemophilia A patients in routine clinical practice.


More From BioPortfolio on "Octapharma"

Advertisement
Quick Search
Advertisement
Advertisement